Branded Generics-United States Market Status and Trend Report 2013-2023
Report Summary
Branded Generics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Branded Generics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Branded Generics 2013-2017, and development forecast 2018-2023
Main market players of Branded Generics in United States, with company and product introduction, position in the Branded Generics market
Market status and development trend of Branded Generics by types and applications
Cost and profit status of Branded Generics, and marketing status
Market growth drivers and challenges
The report segments the United States Branded Generics market as:
United States Branded Generics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Branded Generics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Other
United States Branded Generics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oral
Parenteral
Topical
Other
United States Branded Generics Market: Players Segment Analysis (Company and Product introduction, Branded Generics Sales Volume, Revenue, Price and Gross Margin):
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Valeant Pharmaceuticals International
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Branded Generics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Branded Generics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Branded Generics 2013-2017, and development forecast 2018-2023
Main market players of Branded Generics in United States, with company and product introduction, position in the Branded Generics market
Market status and development trend of Branded Generics by types and applications
Cost and profit status of Branded Generics, and marketing status
Market growth drivers and challenges
The report segments the United States Branded Generics market as:
United States Branded Generics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Branded Generics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Other
United States Branded Generics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oral
Parenteral
Topical
Other
United States Branded Generics Market: Players Segment Analysis (Company and Product introduction, Branded Generics Sales Volume, Revenue, Price and Gross Margin):
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Valeant Pharmaceuticals International
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BRANDED GENERICS
1.1 Definition of Branded Generics in This Report
1.2 Commercial Types of Branded Generics
1.2.1 Alkylating Agents
1.2.2 Antimetabolites
1.2.3 Hormones
1.2.4 Anti-Hypertensive
1.2.5 Lipid Lowering Drugs
1.2.6 Anti-Depressants
1.2.7 Anti-Psychotics
1.2.8 Anti-Epileptics
1.2.9 Other
1.3 Downstream Application of Branded Generics
1.3.1 Oral
1.3.2 Parenteral
1.3.3 Topical
1.3.4 Other
1.4 Development History of Branded Generics
1.5 Market Status and Trend of Branded Generics 2013-2023
1.5.1 United States Branded Generics Market Status and Trend 2013-2023
1.5.2 Regional Branded Generics Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Branded Generics in United States 2013-2017
2.2 Consumption Market of Branded Generics in United States by Regions
2.2.1 Consumption Volume of Branded Generics in United States by Regions
2.2.2 Revenue of Branded Generics in United States by Regions
2.3 Market Analysis of Branded Generics in United States by Regions
2.3.1 Market Analysis of Branded Generics in New England 2013-2017
2.3.2 Market Analysis of Branded Generics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Branded Generics in The Midwest 2013-2017
2.3.4 Market Analysis of Branded Generics in The West 2013-2017
2.3.5 Market Analysis of Branded Generics in The South 2013-2017
2.3.6 Market Analysis of Branded Generics in Southwest 2013-2017
2.4 Market Development Forecast of Branded Generics in United States 2018-2023
2.4.1 Market Development Forecast of Branded Generics in United States 2018-2023
2.4.2 Market Development Forecast of Branded Generics by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Branded Generics in United States by Types
3.1.2 Revenue of Branded Generics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Branded Generics in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Branded Generics in United States by Downstream Industry
4.2 Demand Volume of Branded Generics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Branded Generics by Downstream Industry in New England
4.2.2 Demand Volume of Branded Generics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Branded Generics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Branded Generics by Downstream Industry in The West
4.2.5 Demand Volume of Branded Generics by Downstream Industry in The South
4.2.6 Demand Volume of Branded Generics by Downstream Industry in Southwest
4.3 Market Forecast of Branded Generics in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BRANDED GENERICS
5.1 United States Economy Situation and Trend Overview
5.2 Branded Generics Downstream Industry Situation and Trend Overview
CHAPTER 6 BRANDED GENERICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Branded Generics in United States by Major Players
6.2 Revenue of Branded Generics in United States by Major Players
6.3 Basic Information of Branded Generics by Major Players
6.3.1 Headquarters Location and Established Time of Branded Generics Major Players
6.3.2 Employees and Revenue Level of Branded Generics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BRANDED GENERICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Mylan NV
7.1.1 Company profile
7.1.2 Representative Branded Generics Product
7.1.3 Branded Generics Sales, Revenue, Price and Gross Margin of Mylan NV
7.2 Novartis AG
7.2.1 Company profile
7.2.2 Representative Branded Generics Product
7.2.3 Branded Generics Sales, Revenue, Price and Gross Margin of Novartis AG
7.3 Eva Pharmaceutical Industries
7.3.1 Company profile
7.3.2 Representative Branded Generics Product
7.3.3 Branded Generics Sales, Revenue, Price and Gross Margin of Eva Pharmaceutical Industries
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Branded Generics Product
7.4.3 Branded Generics Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Sun Pharmaceutical Industries
7.5.1 Company profile
7.5.2 Representative Branded Generics Product
7.5.3 Branded Generics Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.6 Aspen Pharmacare Holding
7.6.1 Company profile
7.6.2 Representative Branded Generics Product
7.6.3 Branded Generics Sales, Revenue, Price and Gross Margin of Aspen Pharmacare Holding
7.7 Abbott Laboratories
7.7.1 Company profile
7.7.2 Representative Branded Generics Product
7.7.3 Branded Generics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.8 Valeant Pharmaceuticals International
7.8.1 Company profile
7.8.2 Representative Branded Generics Product
7.8.3 Branded Generics Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BRANDED GENERICS
8.1 Industry Chain of Branded Generics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BRANDED GENERICS
9.1 Cost Structure Analysis of Branded Generics
9.2 Raw Materials Cost Analysis of Branded Generics
9.3 Labor Cost Analysis of Branded Generics
9.4 Manufacturing Expenses Analysis of Branded Generics
CHAPTER 10 MARKETING STATUS ANALYSIS OF BRANDED GENERICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Branded Generics in This Report
1.2 Commercial Types of Branded Generics
1.2.1 Alkylating Agents
1.2.2 Antimetabolites
1.2.3 Hormones
1.2.4 Anti-Hypertensive
1.2.5 Lipid Lowering Drugs
1.2.6 Anti-Depressants
1.2.7 Anti-Psychotics
1.2.8 Anti-Epileptics
1.2.9 Other
1.3 Downstream Application of Branded Generics
1.3.1 Oral
1.3.2 Parenteral
1.3.3 Topical
1.3.4 Other
1.4 Development History of Branded Generics
1.5 Market Status and Trend of Branded Generics 2013-2023
1.5.1 United States Branded Generics Market Status and Trend 2013-2023
1.5.2 Regional Branded Generics Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Branded Generics in United States 2013-2017
2.2 Consumption Market of Branded Generics in United States by Regions
2.2.1 Consumption Volume of Branded Generics in United States by Regions
2.2.2 Revenue of Branded Generics in United States by Regions
2.3 Market Analysis of Branded Generics in United States by Regions
2.3.1 Market Analysis of Branded Generics in New England 2013-2017
2.3.2 Market Analysis of Branded Generics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Branded Generics in The Midwest 2013-2017
2.3.4 Market Analysis of Branded Generics in The West 2013-2017
2.3.5 Market Analysis of Branded Generics in The South 2013-2017
2.3.6 Market Analysis of Branded Generics in Southwest 2013-2017
2.4 Market Development Forecast of Branded Generics in United States 2018-2023
2.4.1 Market Development Forecast of Branded Generics in United States 2018-2023
2.4.2 Market Development Forecast of Branded Generics by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Branded Generics in United States by Types
3.1.2 Revenue of Branded Generics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Branded Generics in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Branded Generics in United States by Downstream Industry
4.2 Demand Volume of Branded Generics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Branded Generics by Downstream Industry in New England
4.2.2 Demand Volume of Branded Generics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Branded Generics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Branded Generics by Downstream Industry in The West
4.2.5 Demand Volume of Branded Generics by Downstream Industry in The South
4.2.6 Demand Volume of Branded Generics by Downstream Industry in Southwest
4.3 Market Forecast of Branded Generics in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BRANDED GENERICS
5.1 United States Economy Situation and Trend Overview
5.2 Branded Generics Downstream Industry Situation and Trend Overview
CHAPTER 6 BRANDED GENERICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Branded Generics in United States by Major Players
6.2 Revenue of Branded Generics in United States by Major Players
6.3 Basic Information of Branded Generics by Major Players
6.3.1 Headquarters Location and Established Time of Branded Generics Major Players
6.3.2 Employees and Revenue Level of Branded Generics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BRANDED GENERICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Mylan NV
7.1.1 Company profile
7.1.2 Representative Branded Generics Product
7.1.3 Branded Generics Sales, Revenue, Price and Gross Margin of Mylan NV
7.2 Novartis AG
7.2.1 Company profile
7.2.2 Representative Branded Generics Product
7.2.3 Branded Generics Sales, Revenue, Price and Gross Margin of Novartis AG
7.3 Eva Pharmaceutical Industries
7.3.1 Company profile
7.3.2 Representative Branded Generics Product
7.3.3 Branded Generics Sales, Revenue, Price and Gross Margin of Eva Pharmaceutical Industries
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Branded Generics Product
7.4.3 Branded Generics Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Sun Pharmaceutical Industries
7.5.1 Company profile
7.5.2 Representative Branded Generics Product
7.5.3 Branded Generics Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.6 Aspen Pharmacare Holding
7.6.1 Company profile
7.6.2 Representative Branded Generics Product
7.6.3 Branded Generics Sales, Revenue, Price and Gross Margin of Aspen Pharmacare Holding
7.7 Abbott Laboratories
7.7.1 Company profile
7.7.2 Representative Branded Generics Product
7.7.3 Branded Generics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.8 Valeant Pharmaceuticals International
7.8.1 Company profile
7.8.2 Representative Branded Generics Product
7.8.3 Branded Generics Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BRANDED GENERICS
8.1 Industry Chain of Branded Generics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BRANDED GENERICS
9.1 Cost Structure Analysis of Branded Generics
9.2 Raw Materials Cost Analysis of Branded Generics
9.3 Labor Cost Analysis of Branded Generics
9.4 Manufacturing Expenses Analysis of Branded Generics
CHAPTER 10 MARKETING STATUS ANALYSIS OF BRANDED GENERICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
